TherVacB

New Concept to Fight Chronic Hepatitis B

TherVacB

New Hope for Hepatitis B Patients

TherVacB – A THERAPEUTIC VACCINE TO CURE HEPATITIS B

European Commission and TherVacB join forces

The role of viral hepatitis as a public health threat has long been underestimated. Only very recently, the United Nations in their “2030 Agenda for Sustainable Development” called for international action to combat viral hepatitis and reduce the disease burden. The major killer is the hepatitis B virus (HBV) causing liver cirrhosis and liver cancer, and worldwide 880,000 humans die each year from the consequences of an HBV infection.

A prophylactic vaccine is available to prevent HBV infection, but more than 3% of the world’s population (about 260 million humans) are chronically infected and do not profit from that vaccine anymore. For those suffering from chronic hepatitis B, until today no curative treatment option exists.

 

The European Commission therefore selected the project TherVacB led by Helmholtz Zentrum München for a five-year funding within the Horizon 2020 program.
A consortium of leading virologists, immunologists and physicians specialized in treating viral hepatitis, will use a newly designed therapeutic vaccine, TherVacB, as an immunotherapy to cure HBV. TherVacB will be evaluated in a three-year clinical trial starting in 2021 conducted in Europe and in Africa. Integration of a partner site in Tanzania shall help building local capacities for diagnosing and treating hepatitis B and support an important goal of the consortium – to raise awareness for hepatitis B.

b3lineicon|b3icon-lifebuoy||Lifebuoy

About TherVacB

b3lineicon|b3icon-user-arrows||User Arrows

For Patients

et|icon_group|

TherVacB Team

Inken Schmütz_400x400

“I am highly pleased that for the clinical trials of TherVacB we are able to cooperate with a consortium of Europe’s leading virologists, immunologists and hepatologis. This will be of great benefit for the patients chronically infected with the hepatitis B virus."

Ulrike Protzer
Project Coordinator
Helmholtz Zentrum München

Partners

European countries

Project duration (months)

World Hepatitis Day 28th July 2020!

World Hepatitis Day 28th July 2020!

Keep in mind! World Hepatitis Day (WHD) takes places every year on 28 July bringing the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. Read more

Animation movie

Enjoy our animation movie to understand the mission and approach of the TherVacB project!

“I’m an invincible Dad, a thoughtful husband. I get tested for Hepatitis B.”
Take care of your health, protect your family, get tested for #hepatitis B.
http://ow.ly/rPHr50A24za @cdchep @HepBUnited @HepBFoundation #KnowHepB #HBV #AAPI #MensHealthMonth

#TherVacB goes online! Have a look at the project's dedicated website under: http://www.thervacb.eu to learn more about our new concept to fight chronic #hepatitisB!

May is #Hepatitis Awareness Month! Help your community be #HepAware2020 by sharing helpful resources and encouraging your followers to get tested and/or vaccinated for #viralhepatitis.

Learn more https://bit.ly/2SdcCpl

Load More...
Share This
TherVacB